Relapsing polychondritis (RP) is a rare autoimmune disease, characterized by episodic inflammatory attacks on cartilaginous tissue. Elastic cartilage of the ears and nose, hyaline cartilage of the peripheral joints, vertebral fibrocartilage, tracheobronchial cartilage, and tissues rich in proteoglycan such as those in the eyes, heart, blood vessels, and inner ear are more likely to be affected. A 35-year-old male presented with complaints of hoarseness, tinnitus and dyspnea for 19 years, with a history of several diagnostic and therapeutic interventions for laryngeal and respiratory tract. He was diagnosed to have inflammation of the tracheobronchial cartilage, cardiac valvulopathy and conductive hearing loss after intensive diagnostic studies. He responded well to low-dose steroids in combination with methotrexate. RP is a diagnostically challenging condition and may cause significant morbidities during diagnosis. RP should be considered in differential diagnosis of airway obstruction as a rare condition.
ıNTRODUCTıON
Relapsing polychondritis (RP) is a rare autoimmune disease, characterized by episodic inflammatory attacks on cartilaginous tissue. While its etiology is yet to be definitely outlined, IgG type antibodies against type 2 collagen are found in nearly half of all affected patients (1) . Initially christened "polychondropathy" by Jacksh-Wartenhorst in 1923, the disease was later renamed as chondromalacia or chronic atrophic polychondritis. In 1960, Pearson et al. used the term "relapsing polychondritis" to describe a series of 12 cases that presented with clinical features that were characteristic of the disease (2) . The incidence of RP is estimated to be around 3-5/ 1.000.000. The disease is not gender specific. While incidences of disease have been reported for every age group, it is more common in individuals in their 4th and 5 th decades (1) . Elastic cartilage of the ears and nose, hyaline cartilage of the peripheral joints, vertebral fibrocartilage, tracheobronchial cartilage, and tissues rich in proteoglycan such as those in the eyes, heart, blood vessels, and inner ear are more likely to be affected by this condition (3).
Herein, this case was reported to draw attention of physician that RP as a rare but significant immunological cause in differential diagnosis of airway obstruction.
CASE
A 35-year-old male patient consulted at our clinic with symptoms of dyspnea, hoarseness and tinnitus that started following an episode of near-drowning 19 years ago. He also had a history of respiratory arrest subsequent to a laryngeal biopsy 13 years ago, tracheostomy, several vocal cord biopsies for hoarseness (reported as inflammation), laryngeal dilation (seven times) and intermittent steroid use (longest time 1 year) for laryngeal problems. Physical examination revealed a tracheostomy scar on the cervical region and extensive keloid-like skin lesions on his entire body. Chest CT reported a lesion in the right vocal cord and a mass obliterating the left main bronchus. An endobronchial lesion at entrance of the left main bronchus was seen in fiberoptic bronchoscopy (FOB); biopsy results revealed the presence of inflammation. The patient was thus referred to our clinic for further diagnosis and evaluation of endobronchial treatment. 3D chest CT revealed heterogeneous soft tissue densities extending from the right paratracheal region to the carinal level.
This manifested as irregularities and nodular indentations in the tracheal lumen which were causing the narrowing of the trachea (Figure 1 ).
Conductive hearing loss was discovered when the patient was referred to an ear-nose-throat specialist for tinnitus. Echocardiography revealed a 2 nd -3 rd degree aortic regurgitation. With these clinical and radiology findings, a PET/CT scan, for probing the relapsing polychondritis, was considered to be imperative to the situation. PET/CT analysis revealed presence of soft tissue extending from the larynx to the right vocal cord along with thickening on the right lateral and anterior walls of the trachea till as far as the carina. This was causing constriction of the air column (SUVmax: 4, 25). Wall thickening on the left and right main bronchus was causing obliteration (SUVmax: 7, 53)( Figure 2 ).
Bronchoscopy was performed and soft lesions with a tendency to bleed were revealed. These tissues originated from the vocal cords and extended so as to encompass all tracheal cartilage prior to protruding into tracheal lumen and obliterating apertures of right and left main bronchus ( Figure 3A,B) . The specimen previously obtained at the referring center was analyzed also at our Pathology Department and inflammation was confirmed. In light of both clinical and radiological findings, the patient was diagnosed with relapsing polychondritis. 
DıSCUSSıON
Two of the most frequent findings in RP are auricular chondritis (95-90%) and nasal chondritis (54-70%). Vasculopathy or cardiac valvulopathy can be seen approximately in 30% of cases (4) . In 50-75% of RP patients, recurrent, non-erosive, migratory arthritis and arthralgia that affects small and large joints can also be seen. Occasionally RP also presents with skin and central (sensorineural hearing loss) and peripheral nervous system involvements. This, however, is a relatively rare occurrence. Ocular inflammation is also known to occur. Renal involvement is rare but when present is associated with a negative prognosis (5) . In 50-55% of the cases, the tracheal cartilage is affected and about 14% of cases present with respiratory tract symptoms. Most common symptoms observed when the respiratory system is involved are hoarseness, cough, wheezing, exertional dyspnea, and stridor. Mortality is 10-50% if there is laryngo-tracheobronchial tree involvement (3).
Echocardiography or cardiac MRI is recommended as a diagnostic tool for the demonstration of cardiac valvulopathy or aortic aneurism (1) . Chest X-Ray are used to observed non-erosive arthropathy. Anterior and lateral airway wall thickening, and posterior membrane involvement is almost patognomonic. The most common CT finding is, as with our case too, thickening of the airway walls and fixed obstruction (6) . Moreover, subglottic stenosis, tracheobronchial luminal narrowing, 
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tracheal cartilage thickening accompanied by dense calcification, peripheral bronchial narrowing, and bronchiectasis can also occur. PET/CT scanning is useful for demonstrating multisystemic cartilage anomalies and for diagnosing RP (7) . RP is associated with a 30% mortality rate and patient prognosis is variable. The most common cause of death is development of pneumonia secondary to airway anomalies and steroid use followed by airway collapse and cardiovascular complications. Early detection of respiratory system involvement is known to considerably reduce mortality (3, (8) (9) (10) .
Disease management involves therapeutic intervention with immunosuppressants such as corticosteroids and dapsone. Additional medications also can be used along with steroids include antirheumatic drugs like azathioprine, anakinra, and abatacept; other supplementary drugs include cyclophosphamide, rituximab, tocilizumab, TNF-α inhibitors and colchicine. The best results were obtained with methotrexate and steroid combination (8) (9) (10) . In our case, he had lowdose steroids in combination with methotrexate and responded well to treatment without any complication.
CONCLUSıON
Even though RP is a comparatively rare disease, by virtue of its simultaneous attack on multiple systems, it has the potential to cause serious complications and mortality. As observed in our case, extensive laryngotracheal cartilage involvement can mimic endobronchial lesions leading to airway obstruction. Therefore, RP should be kept in mind as a rare but significant immunological cause in differential diagnosis of airway obstruction.
